TNF inhibitors are a group of medications that help stop information and are being used widely to treat inflammatory conditions such as rheumatoid arthritis (RA), juvenile arthritis, inflammatory bowel disease, ankylosing spondylitis, psoriatic arthritis, These drugs reduce inflammation and stop disease progression by targeting inflation causing substances called Tumour Necrosis Factor(TNF).
They’re also called TNF blockers, biologic therapies, or anti-TNF drugs.
There are six TNF inhibitors available now, all by prescription only:
- Adalimumab (Humira)
- Adalimumab-atto (Amjevita), a biosimilar to Humira
- Certolizumab pegol (Cimzia)
- Etanercept (Enbrel)
- Etanercept-szzs (Ereizi), a biosimilar to Enbrel
- Golimumab (Simponi, Simponi Aria)
- Infliximab (Remicade)
- Infliximab-dyyb (Inflectra), a biosimilar to Remicade